Soligenix, Inc.
General ticker "SNGX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $6.0M (TTM average)
Soligenix, Inc. does not follow the US Stock Market performance with the rate: -6.1%.
Estimated limits based on current volatility of 3.8%: low 1.51$, high 1.63$
Factors to consider:
- Total employees count: 15 (0.0%) as of 2023
- Top business risk factors: Liquidity and credit risks, Regulatory and compliance, Manufacturing risks, Market acceptance, Market competition
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [1.54$, 4.90$]
- 2025-12-31 to 2026-12-31 estimated range: [0.93$, 3.09$]
Financial Metrics affecting the SNGX estimates:
- Positive: with PPE of -0.5 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -173.37 <= 0.33
- Positive: 41.86 < Shareholder equity ratio, % of 45.93 <= 63.39
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Negative: negative Industry operating cash flow (median)
- Positive: Inventory ratio change, % of 0 <= 0
Short-term SNGX quotes
Long-term SNGX plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.25MM | $0.00MM | $0.00MM |
| Operating Expenses | $14.49MM | $7.70MM | $9.44MM |
| Operating Income | $-14.24MM | $-7.70MM | $-9.44MM |
| Non-Operating Income | $-0.71MM | $-0.21MM | $0.76MM |
| Interest Expense | $0.82MM | $0.05MM | $0.00MM |
| R&D Expense | $7.94MM | $3.31MM | $5.22MM |
| Income(Loss) | $-14.95MM | $-7.91MM | $-8.68MM |
| Taxes | $-1.15MM | $-1.77MM | $-0.41MM |
| Profit(Loss)* | $-13.80MM | $-6.14MM | $-8.27MM |
| Stockholders Equity | $-2.47MM | $2.52MM | $4.12MM |
| Assets | $14.28MM | $9.80MM | $8.97MM |
| Operating Cash Flow | $-12.65MM | $-8.60MM | $-8.40MM |
| Capital expenditure | $0.01MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.01MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $0.08MM | $3.66MM | $7.76MM |
| Earnings Per Share** | $-76.96 | $-12.66 | $-4.98 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.